BKYI — BIO-key International, Inc.

Summary of BIO-key International (BKYI) Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Q3 Revenue: $1.55 million, down from $2.1 million in Q3 2024, primarily due to the absence of large orders that contributed approximately $665,000 in the previous year.
• Year-to-Date Revenue: Approximately $5 million, reflecting a $600,000 decrease compared to the same period in 2024.
• License Fee Revenue: $918,000 in Q3 2025, down from $1.4 million in Q3 2024.
• Service Revenue: Slight increase to $268,000 in Q3 2025.
• Hardware Sales: Decreased to $364,000 from $436,000 year-over-year.
• Gross Margin: Remained strong at 77%, slightly down from 78% in Q3 2024.
• Operating Expenses: Reduced by over 10% year-to-date, totaling $2.1 million in Q3 2025.
• Net Loss: $965,000 or $0.15 per share, compared to a net loss of $739,000 or $0.39 per share in Q3 2024.
• Cash Position: As of September 30, 2025, current assets totaled $3.7 million, including $2 million in cash.

2. Strategic Updates and Business Highlights

• Customer Contracts: Anticipated renewal of a significant banking contract in early 2026, potentially generating $1 million to $3 million in revenue.
• Product Development: Major updates to the PortalGuard identity platform expected by late Q1 or early Q2 2026. Introduction of EcoID III fingerprint scanner aimed at regulated industries.
• Defense Sector Growth: Increased focus on defense contracts, with two of the largest global defense agencies now using BIO-key technology. The company is expanding its partner network to enhance market reach.
• Channel Alliance Program: Continued growth in partnerships, emphasizing quality over quantity, with significant local players in the EMEA region.

3. Forward Guidance and Outlook

• Revenue Expectations: Anticipates a strong close to 2025, with ongoing deployments and customer expansions expected to contribute positively.
• Annual Recurring Revenue (ARR): Estimated to be in the $6 million to $7 million range, with a churn rate in the single-digit percentage.
• Profitability Outlook: Management expressed confidence in reaching breakeven, supported by a growing pipeline and cost management strategies.

4. Challenges and Points of Concern

• Revenue Variability: Noted quarter-to-quarter revenue fluctuations due to timing of larger orders, which may continue to affect performance.
• Dependence on Large Contracts: The business remains sensitive to the timing and size of large customer orders, which can create unpredictability in revenue.
• Market Conditions: While demand is high for security solutions, competition remains strong, and the company must continue to innovate and maintain its unique offerings.

5. Notable Q&A Insights

• Bank of Egypt Contract: Confirmed as a recurring revenue deal with expectations for expanded deployment in 2026.
• Defense Contracts: Recent announcements indicate larger potential contracts in the defense sector, with significant long-term opportunities.
• Market Interest: Management noted unusual trading volumes and interest in the stock, attributing it to recent announcements and the company's unique market position.
• Channel Partners: Some partners exclusively sell BIO-key products, while others offer a range of solutions, highlighting the competitive advantage of BIO-key's biometric offerings.

Overall, while BIO-key faces challenges with revenue fluctuations and market competition, the company is strategically positioned for growth, particularly in the defense and banking sectors, with strong product offerings and a focus on expanding its partner network.